Selected research
Market Outlook & Growth Opportunities
Global Cell Line STR Identification Market Outlook and Growth Opportunities 2026
Market perspective
The global Cell Line STR Identification market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Cell Line STR Identification is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cell Line STR Identification is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cell Line STR Identification is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Cell Line STR Identification market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Cell Line STR Identification market include Bio-Synthesis, Inc., Cell Line Genetics, Inc., Charles River Laboratories, DNA Forensics Lab India, Eurofins Genomics (Eurofins Scientific), GenomeScan, IDEXX Laboratories, Inc., Laboratory Corporation of America Holdings and Microsynth AG, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Cell Line STR Identification market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cell Line STR Identification and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cell Line STR Identification revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cell Line STR Identification market.
Cell Line STR Identification Segment by Company
Bio-Synthesis, Inc.
Cell Line Genetics, Inc.
Charles River Laboratories
DNA Forensics Lab India
Eurofins Genomics (Eurofins Scientific)
GenomeScan
IDEXX Laboratories, Inc.
Laboratory Corporation of America Holdings
Microsynth AG
NorthGene Limited (Biofortuna Limited)
Perfectus Biomed Limited
Promega Corporation
SGS SA
Sigma-Aldrich Co. LLC. (Merck KGaA)
Thermo Fisher Scientific, Inc.
Cell Line STR Identification Segment by Type
Short Tandem Repeat (STR) Analysis
Single Nucleotide Polymorphism (SNP) Analysis
Others
Cell Line STR Identification Segment by Application
Microbial Contamination
Cell Line Identity
Genetic Stability
Virus Testing
Others
Cell Line STR Identification Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Cell Line STR Identification status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Cell Line STR Identification key companies, revenue, market share, and recent developments.
3. To split the Cell Line STR Identification breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Cell Line STR Identification market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Cell Line STR Identification significant trends, drivers, influence factors in global and regions.
6. To analyze Cell Line STR Identification competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Line STR Identification market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Line STR Identification and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Line STR Identification.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell Line STR Identification industry.
Chapter 3: Detailed analysis of Cell Line STR Identification company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Cell Line STR Identification in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Cell Line STR Identification in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Short Tandem Repeat (STR) Analysis
- Single Nucleotide Polymorphism (SNP) Analysis
- Others
Applications
- Microbial Contamination
- Cell Line Identity
- Genetic Stability
- Virus Testing
- Others
Companies covered
- Bio-Synthesis, Inc.
- Cell Line Genetics, Inc.
- Charles River Laboratories
- DNA Forensics Lab India
- Eurofins Genomics (Eurofins Scientific)
- GenomeScan
- IDEXX Laboratories, Inc.
- Laboratory Corporation of America Holdings
- Microsynth AG
- NorthGene Limited (Biofortuna Limited)
- Perfectus Biomed Limited
- Promega Corporation
- SGS SA
- Sigma-Aldrich Co. LLC. (Merck KGaA)
- Thermo Fisher Scientific, Inc.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Cell Line STR Identification Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Cell Line STR Identification Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Cell Line STR Identification Market Dynamics
- 2.1 Cell Line STR Identification Industry Trends
- 2.2 Cell Line STR Identification Industry Drivers
- 2.3 Cell Line STR Identification Industry Opportunities and Challenges
- 2.4 Cell Line STR Identification Industry Restraints
3 Cell Line STR Identification Market by Company
- 3.1 Global Cell Line STR Identification Company Revenue Ranking in 2025
- 3.2 Global Cell Line STR Identification Revenue by Company (2021-2026)
- 3.3 Global Cell Line STR Identification Company Ranking (2024-2026)
- 3.4 Global Cell Line STR Identification Company Manufacturing Base and Headquarters
- 3.5 Global Cell Line STR Identification Company Product Type and Application
- 3.6 Global Cell Line STR Identification Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Cell Line STR Identification Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Cell Line STR Identification Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Cell Line STR Identification Market by Type
- 4.1 Cell Line STR Identification Type Introduction
- 4.1.1 Short Tandem Repeat (STR) Analysis
- 4.1.2 Single Nucleotide Polymorphism (SNP) Analysis
- 4.1.3 Others
- 4.2 Global Cell Line STR Identification Sales Value by Type
- 4.2.1 Global Cell Line STR Identification Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cell Line STR Identification Sales Value by Type (2021-2032)
- 4.2.3 Global Cell Line STR Identification Sales Value Share by Type (2021-2032)
5 Cell Line STR Identification Market by Application
- 5.1 Cell Line STR Identification Application Introduction
- 5.1.1 Microbial Contamination
- 5.1.2 Cell Line Identity
- 5.1.3 Genetic Stability
- 5.1.4 Virus Testing
- 5.1.5 Others
- 5.2 Global Cell Line STR Identification Sales Value by Application
- 5.2.1 Global Cell Line STR Identification Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cell Line STR Identification Sales Value by Application (2021-2032)
- 5.2.3 Global Cell Line STR Identification Sales Value Share by Application (2021-2032)
6 Cell Line STR Identification Regional Value Analysis
- 6.1 Global Cell Line STR Identification Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cell Line STR Identification Sales Value by Region (2021-2032)
- 6.2.1 Global Cell Line STR Identification Sales Value by Region: 2021-2026
- 6.2.2 Global Cell Line STR Identification Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cell Line STR Identification Sales Value (2021-2032)
- 6.3.2 North America Cell Line STR Identification Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Cell Line STR Identification Sales Value (2021-2032)
- 6.4.2 Europe Cell Line STR Identification Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Cell Line STR Identification Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Cell Line STR Identification Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Cell Line STR Identification Sales Value (2021-2032)
- 6.6.2 South America Cell Line STR Identification Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Cell Line STR Identification Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Cell Line STR Identification Sales Value Share by Country, 2025 VS 2032
7 Cell Line STR Identification Country-level Value Analysis
- 7.1 Global Cell Line STR Identification Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Cell Line STR Identification Sales Value by Country (2021-2032)
- 7.2.1 Global Cell Line STR Identification Sales Value by Country (2021-2026)
- 7.2.2 Global Cell Line STR Identification Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.7.2 France Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.14.2 China Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.17.2 India Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Cell Line STR Identification Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Cell Line STR Identification Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Cell Line STR Identification Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Bio-Synthesis, Inc.
- 8.1.1 Bio-Synthesis, Inc. Company Information
- 8.1.2 Bio-Synthesis, Inc. Business Overview
- 8.1.3 Bio-Synthesis, Inc. Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 8.1.4 Bio-Synthesis, Inc. Cell Line STR Identification Product Portfolio
- 8.1.5 Bio-Synthesis, Inc. Recent Developments
- 8.2 Cell Line Genetics, Inc.
- 8.2.1 Cell Line Genetics, Inc. Company Information
- 8.2.2 Cell Line Genetics, Inc. Business Overview
- 8.2.3 Cell Line Genetics, Inc. Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 8.2.4 Cell Line Genetics, Inc. Cell Line STR Identification Product Portfolio
- 8.2.5 Cell Line Genetics, Inc. Recent Developments
- 8.3 Charles River Laboratories
- 8.3.1 Charles River Laboratories Company Information
- 8.3.2 Charles River Laboratories Business Overview
- 8.3.3 Charles River Laboratories Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 8.3.4 Charles River Laboratories Cell Line STR Identification Product Portfolio
- 8.3.5 Charles River Laboratories Recent Developments
- 8.4 DNA Forensics Lab India
- 8.4.1 DNA Forensics Lab India Company Information
- 8.4.2 DNA Forensics Lab India Business Overview
- 8.4.3 DNA Forensics Lab India Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 8.4.4 DNA Forensics Lab India Cell Line STR Identification Product Portfolio
- 8.4.5 DNA Forensics Lab India Recent Developments
- 8.5 Eurofins Genomics (Eurofins Scientific)
- 8.5.1 Eurofins Genomics (Eurofins Scientific) Company Information
- 8.5.2 Eurofins Genomics (Eurofins Scientific) Business Overview
- 8.5.3 Eurofins Genomics (Eurofins Scientific) Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 8.5.4 Eurofins Genomics (Eurofins Scientific) Cell Line STR Identification Product Portfolio
- 8.5.5 Eurofins Genomics (Eurofins Scientific) Recent Developments
- 8.6 GenomeScan
- 8.6.1 GenomeScan Company Information
- 8.6.2 GenomeScan Business Overview
- 8.6.3 GenomeScan Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 8.6.4 GenomeScan Cell Line STR Identification Product Portfolio
- 8.6.5 GenomeScan Recent Developments
- 8.7 IDEXX Laboratories, Inc.
- 8.7.1 IDEXX Laboratories, Inc. Company Information
- 8.7.2 IDEXX Laboratories, Inc. Business Overview
- 8.7.3 IDEXX Laboratories, Inc. Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 8.7.4 IDEXX Laboratories, Inc. Cell Line STR Identification Product Portfolio
- 8.7.5 IDEXX Laboratories, Inc. Recent Developments
- 8.8 Laboratory Corporation of America Holdings
- 8.8.1 Laboratory Corporation of America Holdings Company Information
- 8.8.2 Laboratory Corporation of America Holdings Business Overview
- 8.8.3 Laboratory Corporation of America Holdings Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 8.8.4 Laboratory Corporation of America Holdings Cell Line STR Identification Product Portfolio
- 8.8.5 Laboratory Corporation of America Holdings Recent Developments
- 8.9 Microsynth AG
- 8.9.1 Microsynth AG Company Information
- 8.9.2 Microsynth AG Business Overview
- 8.9.3 Microsynth AG Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 8.9.4 Microsynth AG Cell Line STR Identification Product Portfolio
- 8.9.5 Microsynth AG Recent Developments
- 8.10 NorthGene Limited (Biofortuna Limited)
- 8.10.1 NorthGene Limited (Biofortuna Limited) Company Information
- 8.10.2 NorthGene Limited (Biofortuna Limited) Business Overview
- 8.10.3 NorthGene Limited (Biofortuna Limited) Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 8.10.4 NorthGene Limited (Biofortuna Limited) Cell Line STR Identification Product Portfolio
- 8.10.5 NorthGene Limited (Biofortuna Limited) Recent Developments
- 8.11 Perfectus Biomed Limited
- 8.11.1 Perfectus Biomed Limited Company Information
- 8.11.2 Perfectus Biomed Limited Business Overview
- 8.11.3 Perfectus Biomed Limited Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 8.11.4 Perfectus Biomed Limited Cell Line STR Identification Product Portfolio
- 8.11.5 Perfectus Biomed Limited Recent Developments
- 8.12 Promega Corporation
- 8.12.1 Promega Corporation Company Information
- 8.12.2 Promega Corporation Business Overview
- 8.12.3 Promega Corporation Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 8.12.4 Promega Corporation Cell Line STR Identification Product Portfolio
- 8.12.5 Promega Corporation Recent Developments
- 8.13 SGS SA
- 8.13.1 SGS SA Company Information
- 8.13.2 SGS SA Business Overview
- 8.13.3 SGS SA Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 8.13.4 SGS SA Cell Line STR Identification Product Portfolio
- 8.13.5 SGS SA Recent Developments
- 8.14 Sigma-Aldrich Co. LLC. (Merck KGaA)
- 8.14.1 Sigma-Aldrich Co. LLC. (Merck KGaA) Company Information
- 8.14.2 Sigma-Aldrich Co. LLC. (Merck KGaA) Business Overview
- 8.14.3 Sigma-Aldrich Co. LLC. (Merck KGaA) Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 8.14.4 Sigma-Aldrich Co. LLC. (Merck KGaA) Cell Line STR Identification Product Portfolio
- 8.14.5 Sigma-Aldrich Co. LLC. (Merck KGaA) Recent Developments
- 8.15 Thermo Fisher Scientific, Inc.
- 8.15.1 Thermo Fisher Scientific, Inc. Company Information
- 8.15.2 Thermo Fisher Scientific, Inc. Business Overview
- 8.15.3 Thermo Fisher Scientific, Inc. Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 8.15.4 Thermo Fisher Scientific, Inc. Cell Line STR Identification Product Portfolio
- 8.15.5 Thermo Fisher Scientific, Inc. Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst